⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for plasmablastic lymphoma

Every month we try and update this database with for plasmablastic lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaNCT04139304
Plasmablastic L...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Cyclophosphamid...
Daratumumab
Doxorubicin
Doxorubicin Hyd...
Etoposide
Prednisone
Vincristine
Vincristine Sul...
18 Years - AIDS Malignancy Consortium
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell LymphomaNCT01092182
Burkitt Lymphom...
Diffuse Large B...
Plasmablastic L...
EPOCH-R
EPOCH-RR
18 Years - National Institutes of Health Clinical Center (CC)
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantNCT02797470
HIV Infection
Mature T-Cell a...
Plasmablastic L...
Recurrent Adult...
Recurrent Adult...
Recurrent Burki...
Recurrent Folli...
Stage III Folli...
Stage III Mantl...
Stage IV Follic...
Stage IV Mantle...
Autologous Hema...
Carmustine
Cytarabine
Etoposide
Laboratory Biom...
Lentivirus Vect...
Melphalan
Peripheral Bloo...
18 Years - AIDS Malignancy Consortium
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.NCT04915248
Plasmablastic L...
Daratumumab
Bortezomib
Dexamethasone
18 Years - Fondazione Italiana Linfomi - ETS
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated LymphomasNCT05389423
Diffuse Large C...
Non-Hodgkin Lym...
Burkitt Lymphom...
Plasmablastic L...
B-Cell Neoplasm
Vincristine
Prednisone
Doxorubicin
Etoposide
Pomalidomide
Cyclophosphamid...
Rituximab
18 Years - National Institutes of Health Clinical Center (CC)
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaNCT04139304
Plasmablastic L...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Cyclophosphamid...
Daratumumab
Doxorubicin
Doxorubicin Hyd...
Etoposide
Prednisone
Vincristine
Vincristine Sul...
18 Years - AIDS Malignancy Consortium
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaNCT04139304
Plasmablastic L...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Cyclophosphamid...
Daratumumab
Doxorubicin
Doxorubicin Hyd...
Etoposide
Prednisone
Vincristine
Vincristine Sul...
18 Years - AIDS Malignancy Consortium
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell LymphomasNCT01193842
AIDS-Related Pl...
AIDS-Related Pr...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
HIV Infection
Plasmablastic L...
Primary Effusio...
Recurrent Diffu...
Recurrent Grade...
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide
Laboratory Biom...
Pharmacological...
Prednisone
Rituximab
Vincristine Sul...
Vorinostat
18 Years - National Cancer Institute (NCI)
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell LymphomasNCT01193842
AIDS-Related Pl...
AIDS-Related Pr...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
HIV Infection
Plasmablastic L...
Primary Effusio...
Recurrent Diffu...
Recurrent Grade...
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide
Laboratory Biom...
Pharmacological...
Prednisone
Rituximab
Vincristine Sul...
Vorinostat
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: